This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Inflectra

This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.

Inclusion Criteria:

• Be at least 18 years of age
• Have been diagnosed with RA by a rheumatologist
• Have initiated treatment with Inflectra
• Had assessment of effectiveness in patients who have at least one follow up visit.

Exclusion Criteria:

• No additional exclusion criteria